A. Palikhey, “Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitor Compared to Sulphonylurea in Type II Diabetes Patients Inadequately Controlled with Metformin Alone”, J Univ Coll Med Sci, vol. 10, no. 01, pp. 40–44, Aug. 2022.